BAIBYS Fertility

Company Overview

Snapshot

Founded in January 2020 by Gal Golov and Nino Guy Cassuto, BAIBYS Fertility operates with 1-10 employees. The company has raised $11.3 million across 4 funding rounds from 3 investors. In May 2026, BAIBYS Fertility was recognized as one of the Most Innovative Life Science Startups at Biomed Israel 2026.

Business overview

BAIBYS Fertility develops an AI-based, autonomous robotic system designed for sperm selection in In Vitro Fertilization (IVF) procedures. This technology aims to enhance IVF success rates, mitigate birth defects, and increase clinic revenue by automating a process that traditionally is manual, lengthy, and subjective. The company operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Medical Decision Support, serving healthcare providers and clinics.

Strategic signal

In May 2026, BAIBYS Fertility was awarded as one of the Most Innovative Life Science Startups at Biomed Israel 2026. This recognition highlights the company's innovative approach to fertility treatment and signals strong industry validation for its AI-based robotic system, positioning it as a key player in advancing reproductive technologies.

Company Intelligence Q&A

What significant recognition did BAIBYS Fertility receive recently?

In May 2026, BAIBYS Fertility was awarded as one of the.

What was BAIBYS Fertility's total funding amount as of May 2023?

As of May 2023, BAIBYS Fertility had raised $4.2 million from investors including 14 angel investors who are IVF experts and clinic owners, and Firstime VC.

When did BAIBYS Fertility participate in the MassChallenge Israel accelerator program?

BAIBYS Fertility graduated from the MassChallenge Israel accelerator program in April 2023, which concluded in July 2023.